Synthace set for rapid growth after funding boost

13-Feb-2015 - United Kingdom

Synthace has closed a £2.2 million funding round with new investors SOSventures, Bioeconomy Capital and Rainbow Seed Fund joining Sofinnova Partners and other existing investors. Synthace develops and applies bioengineering tools and working practices, working with industry leaders to accelerate the introduction of bio-based products into the marketplace. Synthace enables bioengineers to move faster, do more and save
money.

“As growth in the global bioeconomy starts to rocket, Synthace offers its blue-chip partners the reproducibility, robustness and productivity necessary to compete in the 21st Century’s biggest revolution,” said Tim Fell, Synthace CEO.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances